91 results
Where innovation meets legacy: the EuroIntervention Turning Point podcast
26 Jun 2025
Welcome to Turning Point, a new podcast series brought to you by EuroIntervention — as part of our 20th anniversary celebration.
How should I manage a patient with insufficient surgical closure of the left atrial appendage
26 Jun 2025
Incomplete surgical LAA closure: how would you proceed?
Despite prior closure with an Atriclip during CABG, transoesophageal echocardiography reveals a persistent LAA gap in a high-risk patient with recurrent bleeding.
Explore the clinical details, imaging, and treatment dilemmas—then share your management approach!
Author
When bleeding risk shapes your PCI strategy
05 Jun 2025
Managing ACS in a high-bleeding-risk patient is always a delicate balance. In this case, an 83-year-old with NSTEMI, advanced CKD, and a recent intracranial hemorrhage presented with a complex mid-to-distal LAD lesion. What would be your strategy?
Author
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...
2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts
20 May 2025
The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
01 Apr 2025
Mirvat Alasnag provides her take on the Lancet Commission for atherosclerosis published during the ACC.25 in Chicago.
Author
International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer
08 Mar 2025
It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...
Author
Aortic Stenosis in Women: causes, symptoms and treatment options
06 Mar 2025
The patient booklets on this page aim to help women get a better understanding of the condition, recognize symptoms, and explore options to get the right care at the right time.
